KR880002542A - 항종양제 - Google Patents
항종양제 Download PDFInfo
- Publication number
- KR880002542A KR880002542A KR1019870008865A KR870008865A KR880002542A KR 880002542 A KR880002542 A KR 880002542A KR 1019870008865 A KR1019870008865 A KR 1019870008865A KR 870008865 A KR870008865 A KR 870008865A KR 880002542 A KR880002542 A KR 880002542A
- Authority
- KR
- South Korea
- Prior art keywords
- agent according
- tumor agent
- interferon
- active substance
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (5)
- 인터로이킨-2 활성물질을 인터페론-α활성물질과 함께 함유하는, 투여경로가 근육내주사인 항종양제.
- 제1항에 있어서, 뮤라밀디펩티드를 더 함유하는 항종양제.
- 제1항에 있어서, 인터로이킨-2활성물질이 재조합 비-글리코실화 인간 이터로이킨-2인 항종양제.
- 제 1 항에 있어서, 인터페론-α 활성물질이 제조합 인터페론-α인 항종양제.
- 제2항에 있어서, 뮤라밀디펩티드가 하기 일반식의 화합물인 항종양제.〔상기식중, R1은 히드록실기 또는 일반식(식중, R7, R8및 R9은 각각 C1-4알킬이고, n은 1∼10의 정수이다)의 카르복실산 잔기이고, R2및 R4는 수소 또는 히드록실기에 의해 임의 치환될 수 있는 C1-6알킬기이며 R4는 히드록실기 또는 C1-6알콕시기이고, R5는 히드록실기 또는 아미노기이다.〕※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19082986 | 1986-08-13 | ||
| JP190829 | 1986-08-13 | ||
| JP20745386 | 1986-09-02 | ||
| JP207453 | 1986-09-02 | ||
| JP157288 | 1987-06-23 | ||
| JP15728887 | 1987-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR880002542A true KR880002542A (ko) | 1988-05-09 |
Family
ID=27321138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019870008865A KR880002542A (ko) | 1986-08-13 | 1987-08-12 | 항종양제 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0257890A3 (ko) |
| KR (1) | KR880002542A (ko) |
| CA (1) | CA1292685C (ko) |
| DK (1) | DK399487A (ko) |
| IL (1) | IL83350A0 (ko) |
| NZ (1) | NZ221406A (ko) |
| PH (1) | PH25113A (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
| US5183746A (en) * | 1986-10-27 | 1993-02-02 | Schering Aktiengesellschaft | Formulation processes for pharmaceutical compositions of recombinant β- |
| US5004605A (en) * | 1987-12-10 | 1991-04-02 | Cetus Corporation | Low pH pharmaceutical compositions of recombinant β-interferon |
| FR2639232A1 (fr) * | 1988-10-21 | 1990-05-25 | Sanofi Sa | Medicaments contenant une interleukine-2 glycosylee |
| FR2702659B1 (fr) * | 1993-03-19 | 1995-08-25 | Vacsyn Sa | Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine. |
| CA2157758A1 (en) * | 1993-03-19 | 1994-09-29 | Louis Chedid | Compositions for use in human therapeutics, characterised by the association of a muramyl peptide with a cytokine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0751511B2 (ja) * | 1982-03-15 | 1995-06-05 | 味の素株式会社 | インターロイキン２を含有してなる癌治療剤 |
| EP0149551A3 (en) * | 1984-01-16 | 1987-09-23 | Genentech, Inc. | Gamma interferon-interleukin-2 synergistic compositions and processes therefor |
| DK585886A (da) * | 1985-12-24 | 1987-06-25 | Takeda Chemical Industries Ltd | Immunstimulerende middel og anvendelse deraf |
| US4736634A (en) * | 1985-12-27 | 1988-04-12 | Aichi Tokei Denki Co., Ltd. | Magnetic field generating device for electromagnetic flowmeter of residual magnetization type |
-
1987
- 1987-07-27 IL IL83350A patent/IL83350A0/xx unknown
- 1987-07-31 DK DK399487A patent/DK399487A/da not_active Application Discontinuation
- 1987-08-07 EP EP87307023A patent/EP0257890A3/en not_active Withdrawn
- 1987-08-11 NZ NZ221406A patent/NZ221406A/xx unknown
- 1987-08-12 KR KR1019870008865A patent/KR880002542A/ko not_active Application Discontinuation
- 1987-08-12 CA CA000544281A patent/CA1292685C/en not_active Expired - Lifetime
- 1987-08-12 PH PH35658A patent/PH25113A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1292685C (en) | 1991-12-03 |
| DK399487D0 (da) | 1987-07-31 |
| IL83350A0 (en) | 1987-12-31 |
| DK399487A (da) | 1988-02-14 |
| NZ221406A (en) | 1990-10-26 |
| EP0257890A2 (en) | 1988-03-02 |
| PH25113A (en) | 1991-02-19 |
| EP0257890A3 (en) | 1989-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910011896A (ko) | 신규한 글리코펩티드 유도체 | |
| KR870004099A (ko) | 실리콘 조성물 | |
| AR005999A1 (es) | Nuevos derivados de eritromicina, su procedimiento de preparacion, composiciones farmaceuticas y medicamentos | |
| KR890008086A (ko) | 사이클로헥산 유도체 | |
| FI870589A0 (fi) | Ny farmaceutisk sammansaettning och foerfarande foer framstaellning av den. | |
| KR880002542A (ko) | 항종양제 | |
| KR910700320A (ko) | 불소화 올리고페닐을 함유한 액정 매질 | |
| KR900009606A (ko) | 불소-함유 2-니트로 이미다졸 유도체 및 그를 함유하는 방사선 증감제 | |
| KR890005336A (ko) | 합성섬유처리용 내열성 유제 조성물 | |
| KR910000778A (ko) | 에토포시드의 아실화 유도체 | |
| KR920016089A (ko) | 제i형 당뇨병의 치료방법 | |
| KR850001774A (ko) | Lh/rh길항성 펩티드의 제조방법 | |
| KR880011112A (ko) | 벤즈아제핀 설폰아미드 화합물 | |
| KR900002774A (ko) | 주사제 | |
| KR920701220A (ko) | 신규의 복핵 백금 착체 및 이를 유효성분으로하는 항종양제 | |
| KR910004557A (ko) | 2,4,6-치환 페놀 유도체 | |
| KR940007058A (ko) | 글리코실화 사이토킨 | |
| KR950700065A (ko) | 진해제(Antitussive) | |
| KR900009675A (ko) | 신규 백금 착화합물 | |
| KR930005999A (ko) | 티오우레아 유도체 및 이를 함유하는 항균제 및 항궤양제 | |
| KR890003793A (ko) | 3'-데메톡시에피포도필로톡신 배당체의 유도체 | |
| KR920018076A (ko) | 신규 폴리펩티드 | |
| KR910004620A (ko) | 위궤양 치료제 | |
| KR910700054A (ko) | B형 간염 비루스 감염의 예방 및 치료를 위한 방법 및 조성물 | |
| JPS6462170A (en) | Modified polysiloxane coated sanitary rubber product and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITB | Written withdrawal of application |